BR0012599A - Método para preparação de debromohimenialdisina e análogos desta - Google Patents

Método para preparação de debromohimenialdisina e análogos desta

Info

Publication number
BR0012599A
BR0012599A BR0012599-7A BR0012599A BR0012599A BR 0012599 A BR0012599 A BR 0012599A BR 0012599 A BR0012599 A BR 0012599A BR 0012599 A BR0012599 A BR 0012599A
Authority
BR
Brazil
Prior art keywords
compound
dbh
converted
hydrogen
hymenin
Prior art date
Application number
BR0012599-7A
Other languages
English (en)
Inventor
David A Horne
Kenichi Yakushijin
Original Assignee
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State filed Critical Oregon State
Publication of BR0012599A publication Critical patent/BR0012599A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

"MéTODO PARA PREPARAçãO DE DEBROMOHIMENIALDISINA E ANáLOGOS DESTA". Um método para preparar debromohimenialdisina (DSH) 2 e análogos desta é descrito. Uma modalidade do presente método primeiro compreende formar himenina 4, e em seguida converter a himenina em DBH 2 como aqui descrito. Uma tal modalidade primeiro compreende prover um composto tendo a Fórmula (3) onde R é independentemente selecionado do grupo consistindo em hidrogênio e alifático inferior, e X é independentemente selecionado do grupo consistindo em hidrogênio e halogênio. Um composto tendo a Fórmula (3), tal como o Composto 10 com R e X como hidrogênio, é então convertido em DBH 2 ou um análogo deste. Uma modalidade alternativa do composto compreende formar o Composto 30 ou o Composto 32, que são então diretamente convertidos em DBH 2. Alternativamente, o Composto 30 pode ser convertido em Composto 10, que é então subseq³entemente convertido em DBH 2 por reação com um halogênio na presença de um ácido. O método da presente invenção pode ser empregado para preparar análogos de DBH 2, incluindo derivados de alcóxi, tal como o Composto 12, e os derivados de dieno conjugados, tal como o Composto 14.
BR0012599-7A 1999-07-20 2000-07-19 Método para preparação de debromohimenialdisina e análogos desta BR0012599A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/357,687 US6211361B1 (en) 1999-07-20 1999-07-20 Method for making debromohymenialdisine and analogs thereof
PCT/US2000/019704 WO2001005794A2 (en) 1999-07-20 2000-07-19 Method for making debromohymenialdisine and analogs thereof

Publications (1)

Publication Number Publication Date
BR0012599A true BR0012599A (pt) 2002-09-17

Family

ID=23406630

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012599-7A BR0012599A (pt) 1999-07-20 2000-07-19 Método para preparação de debromohimenialdisina e análogos desta

Country Status (12)

Country Link
US (1) US6211361B1 (pt)
EP (1) EP1200438B1 (pt)
JP (1) JP2003505392A (pt)
AT (1) ATE277051T1 (pt)
AU (1) AU6112800A (pt)
BR (1) BR0012599A (pt)
CA (1) CA2379847A1 (pt)
DE (1) DE60014103D1 (pt)
IL (1) IL147728A0 (pt)
MX (1) MXPA02000706A (pt)
WO (1) WO2001005794A2 (pt)
ZA (1) ZA200201159B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1572682A4 (en) * 2002-12-20 2008-01-23 Pharmacia Corp ACYCLIC PYRAZOLE COMPOUNDS
US7423031B2 (en) 2003-05-01 2008-09-09 Irm Llc Compounds and compositions as protein kinase inhibitors
WO2004103958A2 (en) * 2003-05-19 2004-12-02 Michigan State University Preparation of hymenialdisine derivatives and use thereof
WO2008147713A1 (en) * 2007-05-24 2008-12-04 The Regents Of The University Of California Wnt signaling inhibitors, and methods for making and using them
DE102017124284A1 (de) * 2016-10-19 2018-04-19 Steering Solutions Ip Holding Corporation In eine controllerplatine integrierter drehmomentsensor und eps-system, das diese enthält

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016703A1 (en) * 1992-02-24 1993-09-02 Smithkline Beecham Corporation Protein kinase c inhibitor
JP3714685B2 (ja) * 1994-05-18 2005-11-09 第一サントリーファーマ株式会社 ハイメニアルディシン及びその誘導体並びにそれらの合成中間体の製造法並びにその合成中間体
US5591740A (en) * 1995-06-07 1997-01-07 Osteoarthritis Sciences, Incorporated Use of debromohymenialdisine for treating osteoarthritis

Also Published As

Publication number Publication date
MXPA02000706A (es) 2002-07-02
ATE277051T1 (de) 2004-10-15
ZA200201159B (en) 2003-08-27
JP2003505392A (ja) 2003-02-12
AU6112800A (en) 2001-02-05
US6211361B1 (en) 2001-04-03
IL147728A0 (en) 2002-08-14
EP1200438B1 (en) 2004-09-22
DE60014103D1 (de) 2004-10-28
EP1200438A2 (en) 2002-05-02
WO2001005794A2 (en) 2001-01-25
WO2001005794A3 (en) 2001-07-19
CA2379847A1 (en) 2001-01-25

Similar Documents

Publication Publication Date Title
HUP0302755A2 (hu) Eljárás kamptotecin-analóg vegyületek előállítására
GR20010100097A (el) Μεθοδος παρασκευης της σιταλοπραμης
GR20010100398A (el) Μεθοδος παρασκευης της σιταλοπραμης.
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
HUP0002101A2 (hu) Fluor-étert tartalmazó érzéstelenítőszerek, eljárás előállításukra, valamint stabilizálásukra
GB0005477D0 (en) Process for the preparation of citalopram
IL152348A0 (en) Oxidation process for preparing the intermediate 6.alpha.-difluoro-11.beta., 17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid
EA200000431A2 (ru) Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их
ATE233484T1 (de) Desinfizierende zusammensetzung
BR0012599A (pt) Método para preparação de debromohimenialdisina e análogos desta
EA200200939A1 (ru) Способ получения циталопрама
UA66866C2 (uk) Синтез морфолінових похідних
BR0109268A (pt) Método de preparação de citalopram, composto e citaplopram
DE60222244D1 (de) Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga
TR200000196T2 (tr) Avermektin bileşiklerinin üretimi.
ID27440A (id) Proses untuk menyiapkan penengah-penengah
EA200300400A1 (ru) 17α-ФТОРАЛКИЛСТЕРОИДЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
UA41340C2 (uk) Похідні циклогексанкарбонової кислоти, суміш їх ізомерів або окремі ізомери і фізіологічно прийнятні солі і фармацевтична композиція з активністю, що гальмує ферментний комплекс глюкоза-6-фосфатази
NO20022690L (no) Nye strukturelle analoger av Vitamin D
DE60003711D1 (de) Verfahren zur herstellung von peptidzwischenprodukten
ATE247632T1 (de) Verfahren zur herstellung von cyanessigsäureestern
FR2791666B1 (fr) Diol fluore et son procede de preparation
IL145017A0 (en) METHOD FOR PRODUCING 4,4-DIMETHYL-3β-HYDROXYPREGNA-8,14-DIENE-21 -CARBOXYLIC ACID ESTERS AND INTERMEDIATE PRODUCTS OBTAINED BY SAID METHOD
WO2002070450A3 (de) Verfahren zur herstellung von glycerinsäuren

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]